Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Summary by Financial Post
DHARWAD, India — Shilpa Medicare Limited announced that its wholly owned subsidiary, Shilpa Biologicals Private Limited, has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of […]

6 Articles

The HinduThe Hindu
+4 Reposted by 4 other sources
Lean Left

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

Orion and Shilpa Medicare Expand Partnership to Develop and Supply Nivolumab Biosimilar for Europe

·Chennai, India
Read Full Article
fiinews.comfiinews.com

Market: Shilpa to supply IV to Europe

Bhutada works on deliver of complex biologics at scale Shilpa Biologicals Private Limited of India has entered into a co-development and supply agreement with Orion Corporation for intravenous (IV) nivolumab biosimilar referencing one of the world’s most widely used cancer immunotherapies to widen patient access across Europe. Nivolumab helped usher in the era of immuno-oncology, […] Source

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 67% of the sources lean Right
67% Right

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Latestly broke the news in Mumbai, India on Monday, July 6, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)

Similar News Topics

Dharwad icon

Dharwad

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal